Sleep pressure homeostatically increases during wake and dissipates during sleep, but the molecular signals and neuronal substrates that measure homeostatic sleep pressure remain poorly understood. A pharmacological assay that generates acute, short-term increases in wakefulness in larval zebrafish, revealed that subsequent rebound sleep is dependent on the intensity of global neuronal activity. Whole brain activity mapping identified preoptic Galanin expressing neurons as selectively active during rebound sleep, and the induction of galanin transcripts was predictive of total rebound sleep time. Galanin is required for sleep homeostasis, as galanin mutants almost completely lack rebound sleep following both pharmacologically induced neuronal activity and physical sleep deprivation. These results suggest that Galanin expressing neurons play a key role in integrating sleep pressure signals derived from global neuronal activity and act as an output arm for the vertebrate sleep homeostat. (word count: 129).
Introduction
Animals sleep at specific times of day. This timing, as well as the depth and quantity of sleep, are regulated by two interacting processes: a circadian, 24-hour process that sets sleep relative to the phase of the day/night cycle and a homeostatic process that increases the drive to sleep as a function of prior wakefulness (Borbely, 1982) . While the molecular and neuronal underpinnings of circadian rhythms are fairly well understood, the mechanisms that measure and actuate homeostatic sleep pressure are only starting to be elucidated in flies (Donlea, 2017; Liu et al., 2016) and in vertebrates (Funato et al., 2016) .
Because extended wakefulness is followed by longer and more intense rebound sleep (Borbely and Achermann, 1999) , many hypotheses of sleep homeostasis converge on metabolic or synaptic correlates of wake-driven neuronal activity.
Hypotheses of neuronal fatigue suggest that during extended wake, neurons can no longer sustain firing rates after the depletion of critical resources, such as glycogen or lipids essential for secretory vesicles (Benington and Heller, 1995; Scharf et al., 2008; Vyazovskiy and Harris, 2013) . Active neurons may also produce sleep signaling substances that are direct by-products of metabolic activity, such as extracellular adenosine (Porkka-Heiskanen and Kalinchuk, 2011 ), intracellular calcium (Ode et al., 2017 or nitric oxide (Kalinchuk et al., 2010) .
Alternatively, it has been proposed that activity-dependent gains in synaptic potentiation during wake may trigger stronger synaptic coupling and increased neuronal synchrony, which in turn is associated with synaptic downscaling and neuronal plasticity during sleep (Tononi and Cirelli, 2016) . Which of these mechanisms, alone or in combination, are most critical for driving sleep homeostasis remains unclear.
A critical question to be addressed is how these still ill-defined correlates of wakedriven neuronal activity are sensed at the level of single neurons and transformed into global, whole animal sleep? One of the major hallmarks of rebound sleep following sleep deprivation in mammals is an increase in cortical slow-wave activity (SWA) during non-REM (NREM) sleep, which dissipates in intensity as sleep progresses (Bellesi et al., 2014) . However, SWA intensity is not uniform across the brain but is locally increased during NREM sleep as a function of local brain use during prior wakefulness (Finelli et al., 2001; Huber et al., 2004; Werth et al., 1997) .
These observations have led to the concept of local "sleep", in which homeostatic sleep pressure is predominantly sensed and regulated by ensembles of active neurons . In this model, wake-active cortical neurons generate sleep pressure locally, either through the release of sleep-promoting substances or changes in synaptic strength, which alters the firing properties of cortical neurons to drive locally increased SWA . Less clearly explained by theories of local sleep is how local increases of SWA in neuronal assemblies would co-ordinately drive whole organismal sleep, although mathematical modelling has suggested whole animal sleep is an emergent property as the number of simultaneous "offline" assemblies increases . Importantly, behavioral sleep is maintained even after local increases in sleep pressure have dissipated and local, wake-like up states have returned, (Finelli et al., 2001; Werth et al., 1997) , suggesting that non-local factors contribute to reinforce and maintain appropriate whole organismal sleep.
An alternative view hypothesizes that sleep is imposed upon the brain by the activity of centrally acting, circadian-and homeostatic-sensitive sleep-promoting neurons. Numerous classes of neuronal sub-populations in both Drosophila and mammals have been identified that are capable of driving sleep and wake when stimulated by opto-and chemogenetic approaches (Chen et al., 2018; Chung et al., 2017; Donlea et al., 2014; Donlea et al., 2018; Kroeger et al., 2018; Seidner et al., 2015; Xu et al., 2015) . In addition, focal lesions of some brain nuclei, for example the mammalian ventro-lateral preoptic area (VLPO), can cause severe insomnia (Lu et al., 2000) , demonstrating that a loss of a small number of critical neurons can have a large effect on sleep. Importantly, several of these sleepinducing neurons are either directly or indirectly sensitive to homeostatic sleep signals. For example, in Drosophila, two classes of sleep regulatory neurons change electrophysiological properties in response to sleep need (Donlea, 2017; Liu et al., 2016) , while in vertebrates, neurons in the VLPO increase firing in response to sleep pressure following sleep deprivation (Szymusiak 1998) and are also sensitive to putative homeostatic sleep pressure signals such as adenosine (Chamberlin et al., 2003) . However, whether specific vertebrate sleep-promoting centres are critical for sensing and driving sleep homeostasis has not been demonstrated.
Here we show that pharmacologically induced neuronal activity drives homeostatic sleep pressure in zebrafish larvae and find that sleep pressure is a function of global neuronal activity, which can be decoupled from prior waking time. We further show that both neuronal activity and classic sleep deprivation engage Galaninpositive neurons in the preoptic area, and galanin is required for appropriate increases in subsequent homeostatic rebound sleep. Our data support a model in which global brain activity is ultimately integrated by rebound-sleep inducing, Galanin expressing neurons of the vertebrate hypothalamus to coordinate sleep behavior.
Results
Short-term, pharmacologically induced increases in neuronal activity are followed by homeostatic rebound sleep in zebrafish If the activity of neuronal ensembles across the brain is integrated to drive homeostatic rebound sleep, we hypothesized that short-term pharmacological activation of neuronal activity should accelerate homeostatic sleep pressure accumulation to dose-dependently trigger rebound sleep when the drugs are removed. The diurnal larval zebrafish is an ideal model to test this hypothesis because arousing drugs placed directly in the water are absorbed into the brain to rapidly modulate behavior, including sleep and wakefulness . Drug induced behaviour is also rapidly reversible, as compounds can be readily removed by washout (Mussulini et al., 2013; Tran et al., 2014) . As a proof of concept, we first evaluated the effects of short-term exposure to the GABA-A receptor antagonist pentylenetetrazol (PTZ), which is known to potently and dose-dependently induce neuronal and behavioral hyperactivity in larval zebrafish (Baraban et al., 2005) . Larvae raised and behaviorally tracked on a 14:10 light:dark cycle at 6 days post fertilization (dpf) were exposed to PTZ in the water for 1 hour in the morning, when homeostatic sleep pressure is low. Larvae treated with 10 mM PTZ increased their swimming activity and exhibited seizurelike behavior during the drug exposure, as has previously been described (Fig.1A,   S1F ). Following drug removal (washout), PTZ-treated larvae rapidly ceased to exhibit high frequency swim bouts ( Fig. S1F ) and entered a state of behavioral inactivity (rebound phase), which lasted until the end of the day/light period ( Fig.   1A,B ). Importantly, larval activity and sleep returned to normal control levels on the following day ( Fig. S1 A,B ).
To demonstrate that the inactive state observed following PTZ exposure is a bona fide, physiological sleep state, we tested whether post PTZ inactivity fulfils the key sleep behavioural criteria that have been previously established in zebrafish and other non-mammalian species (Hendricks et al., 2000; Prober et al., 2006; Raizen et al., 2008; Yokogawa et al., 2007; Zhdanova et al., 2001) . Firstly, periods of continuous inactivity that last longer than one minute have been established as sleep in larval zebrafish and long rest bouts are rarely observed during the circadian light period when the diurnal zebrafish are predominantly awake (Prober et al., 2006; . Following exposure to PTZ, the total time spent asleep was significantly increased due to the lengthening of individual sleep bouts by an average of 1.7 fold and an increase in the number of sleep bout initiations (e.g. Fig. S2I ). Secondly, sleep is accompanied by an increased arousal threshold to stimuli. Following 10mM PTZ-exposure, larvae showed lowered responsiveness to a series of mechano-acoustic tapping stimuli of varying strengths delivered during the rebound sleep phase ( Fig. S1C ) (Burgess and Granato, 2007; . Third, unlike during paralysis or a coma, sleep is reversible with strong, salient stimuli. Following PTZ exposure, larvae responded to a series of 10 minute dark pulses with characteristic increases in locomotor behavior (Emran et al., 2007) , similar to controls ( Fig. S1D) , with the exception of the dark pulse immediately after drug washout. Furthermore, behavioral inactivity following PTZexposure is also unlikely to be due to neuronal injury, as markers of apoptosis, including activated Caspase-3 ( Fig. S1E , see also Fig. S5A ) are not induced by drug exposure, and neither larval morphology or sleep/wake behaviour was altered one day following treatment ( Fig. 1A, S1A ,B). Together, these data indicate that inactivity following acute drug-induced neuronal hyperactivity is a physiologically sleep-like state comparable to physiological sleep.
Finally, to test whether PTZ-induced rebound sleep is under homeostatic control, we hypothesized that the amount of rebound sleep following PTZ exposure should correlate to the amount of PTZ administered, as the effects of PTZ on neuronal firing and behavioural hyperactivity have been shown to increase with increasing dose (Baraban et al., 2005; . Indeed, the mean activity and sleep of PTZ-treated larvae during the rebound phase varied dosedependently ( Fig. 1C,D) , with total sleep accumulation increasing for many hours after drug exposure ( Fig 1E) . Thus, in addition to fulfilling the key behavioral features of sleep, PTZ-induced rebound sleep is under homeostatic regulation.
Pharmacologically-induced rebound sleep is independent of physical hyperactivity, seizure induction, and pharmacological target
Since PTZ represents an extreme test case that induces high levels of neuronal activity, including seizures, we next tested additional, pharmacologically diverse drugs that promote neuronal activity and behavioural wakefulness in zebrafish larvae, including the adenosine receptor antagonist caffeine, the voltageactivated potassium channel antagonist 4-aminopyridine (4-AP), and the voltagegated sodium channel agonist aconitine, one of the most potent modulators of behavioral wakefulness in zebrafish . Because these drugs have distinct pharmacological targets as well as diverse effects at the behavioural and neuronal levels, the features of drug-induced hyperactivity that are required to elicit rebound sleep can be dissected. Similar to PTZ, exposure to both caffeine and 4-AP for 1 hour induced significant increases in rebound sleep after Finally we observed that only PTZ and 4-AP, but not caffeine, generated behavioural (or by calcium imaging, see below) seizures as measured by the number of high frequency swim bouts ( Fig. S1F ). Overall, these results indicate that pharmacologically-induced rebound sleep is independent of physical activity, the presence of seizures, and pharmacological target and demonstrates that the degree of behavioural, physical arousal during exposure does not predict rebound sleep behaviour.
Pharmacologically-induced rebound sleep is a function of global neuronal activity
Given that pharmacological target, presence or absence of behavioural seizures, and degree and duration of physical activity do not predict the ability of compounds to elicit post-washout rebound sleep, we speculated that the divergent response to these drugs could be explained by differential stimulation of global neuronal activity. To examine this possibility, we measured expression of the immediate early gene c-fos, a well-established correlate for neuronal activity (Baraban et al., 2005; Chung, 2015) , directly after exposure to aconitine, caffeine, 4-AP and PTZ.
All drugs that elicit rebound sleep -caffeine, 4-AP and PTZ -strongly induced cfos mRNA expression in widespread neuronal populations ( Fig. 2A,B ). In contrast, aconitine, which fails to induce rebound sleep, increased c-fos only in a small region of the dorsal telencephalon, resulting in a low overall induction of c-fos expression ( Fig. 2A,B ). Total c-fos expression measured at the end of the drug exposure strongly correlated with the amount of subsequent rebound sleep that is induced across drugs (R 2 =0.96, linear regression) and as a function of both caffeine and PTZ dose (R 2 =0.99 and R 2 =0.93, linear regression, Fig. 2C -F). In contrast, neither the amplitude nor the duration of physical activity during drug exposure correlated with subsequent rebound sleep, suggesting that locomotion alone cannot account for homeostatic sleep drive ( Fig. 2G-H; S3A) . These results support the hypothesis that signals from global neuronal activity are integrated to trigger homeostatic sleep.
While immediate early genes such as c-fos are widely used as correlates of neuronal activity, some active neurons do not induce c-fos, and other neurons exhibit inconsistent c-fos transcriptional induction during repeated rounds of enhanced activity (Kovacs, 2008) . To corroborate the c-fos measurements of druginduced neuronal activity, we turned to in vivo wide-field Ca 2+ imaging as a second readout of neuronal firing . Using Tg(elav3:H2B-GCaMP6s) transgenic larvae, which express the pan-neuronal, nuclear-localized geneticallyencoded Ca 2+ indicator GCaMP6s (Freeman et al., 2014) , we measured total fluorescence changes across the whole brain over a 1 hour exposure to DMSO, 5 µM aconitine, 2 mM caffeine and 10 mM PTZ (see Extended Methods). Consistent with the c-fos expression measurements, PTZ and caffeine, but not the DMSO control, caused a measureable increase in total fluorescence above baseline, while aconitine caused a global decrease in activity ( Fig. 2I ; S3B-F, Supplemental Movies 1-3). Additionally, although 2mM caffeine upregulated neuronal activity in many areas of the brain, only PTZ produced detectable seizures, observed as large, rapid, and synchronized increases in fluorescence followed by a rapid decrease in global fluorescence levels ( Together, these data indicate that increases in global measures of neuronal activity during drug-induced wakefulness vary across drugs and predict the amount of subsequent rebound sleep after drug removal, whereas neither the presence of seizures nor the intensity of physical activity correlate with rebound sleep amount ( Figure 2J ).
Galanin expressing neurons of the preoptic area are active during rebound sleep
We hypothesized that the identity of candidate sleep-control neurons that are activated during rebound sleep might provide clues to how brain-wide neuronal activity during waking is integrated to generate the appropriate amount of subsequent rebound sleep. We therefore turned to whole-brain activity mapping to identify rebound sleep-active neurons following pharmacologically induced neuronal activity. We used mitogen activated protein kinase (MAP)mapping , which has been shown to be a reliable readout of neuronal activity in zebrafish larvae, to create whole brain neural-activity maps 4 hours into pharmacologically-induced rebound sleep. Larval brain activity maps during post-PTZ ( Fig. 3A -A'') or post-caffeine ( Fig. 3C -C'') rebound sleep showed several areas with altered activity (FDR threshold: <5x10 -5 ) compared to control brains, which were identified by morphing onto the Z-brain reference atlas (Supplemental Table 1 ). Areas with a significant increase in pERK/tERK activity during rebound Table 1 ).
One set of neurons that were activated during both PTZ and caffeine induced rebound sleep were found in the preoptic area (POA) ( Fig. 3A -A'',C-C'', Supplemental Table 1 ), the zebrafish homolog of the mammalian ventro-lateral preoptic area (VLPO), which contains sleep-active neurons that express the inhibitory neuropeptide Galanin (Galn) (Kroeger et al., 2018) . We morphed a galn fluorescent ISH image onto the same reference brain and found a strong overlap in sleep-active pERK/tERK signals and galn expression in the POA ( Fig. 3B-B '',D-D''). In addition, although the resolution of MAP-mapping for sparsely, nonstereotypically distributed neurons is more limited, we observed increased neuronal activity in the anterior hypothalamus, where galn is also expressed in zebrafish ( Fig. 3B-B '',D-D''). These data indicate that at least one important sleepactive centre of the mammalian brain, the Galanin expressing VLPO, is also active during rebound sleep in zebrafish.
galanin expression correlates with rebound sleep pressure
Increased neuronal activity is often accompanied by changes in neurotransmitter transcription rates via 'stimulus-secretion-synthesis coupling' (MacArthur and Eiden, 1996) , presumably as a mechanism to replenish neuropeptide stores after secretion. We therefore tested whether the increased activity of Galn neurons during rebound sleep led to upregulation in galn transcription. Indeed, galn expression increased steadily to 3-4 fold after both PTZ and caffeine washout during the rebound sleep phase (Fig. 3E,F) , and returned to baseline the next day If galn expression is increased during rebound sleep as a function of heightened sleep pressure generated by increased neuronal activation, we predicted that the magnitude of galn induction would reflect both the magnitude of whole-brain neuronal activity generated during drug exposure as well as the total amount of subsequent rebound sleep. Indeed, galn transcription during rebound sleep is highly correlated with the dose-dependent increase in c-fos after PTZ exposure (R 2 =0.96, linear regression) as well as across drugs (R 2 =0.96, linear regression) ( Fig. 3J ,K). Moreover, galn expression levels are a good readout of the amount of sleep rebound induced by both PTZ and across drugs (R 2 =0.98 and 0.82 respectively, Fig. 3L ,M). In contrast, galn transcription is uncorrelated to both the magnitude and the duration of physical activity (Fig. S3E ,F) suggesting that neuronal, but not physical, activity contributes to homeostatic rebound sleep. galanin mutants have reduced sleep but no increased seizure susceptibility Whole brain activity mapping and galn expression analysis suggest that Galanin expressing neurons are recruited during pharmacologically-induced rebound sleep in response to increased sleep pressure. To further examine the role of galn in regulating rebound sleep states, we used Crispr-Cas9 to generate two zebrafish galn mutant alleles targeting the 3 rd exon ( Fig. S4A,B ; see Extended Methods).
Both are likely functionally null alleles of galn, as galn transcripts are greatly reduced, an indicator of nonsense-mediated decay (galn int3 ; Fig. S4C ), and Galn peptide is not detectable by whole mount immunohistochemistry (galn i8 ; Fig. S4D ).
Both alleles are homozygous viable and fertile as adults, and they lack overt morphological phenotypes, with the exception of a pigmentation defect.
Both homozygous galn i8/i8 and galn int3/int3 larvae show small but consistent disruptions in their sleep/wake structure compared to their wild type and heterozygous siblings when tracked in a 14:10 light:dark cycle over several days ( Fig. 4A ,B, and Fig. S4E-G) . During the day, both galn int3/int3 and galn i8/i8 mutants have a significant reduction in sleep compared to sibling controls, due to both the initiation of fewer and shorter sleep bouts ( Fig. 4B, S4E ). Daytime sleep latency (i.e. time until the first rest bout from lights ON) is also increased (Fig. 4B, S4E) and average activity as well as waking activity during the day is higher in both galn int3/int3 and galn i8/i8 mutants. Total sleep and average sleep bout lengths at night are significantly but modestly reduced in galn int3/int3 (Fig. 4B, S4E ), suggesting that galn is largely dispensable or redundant for maintaining sleep during the circadian night.
Galn has been reported to play a neuroprotective role, for example after seizure and neuronal injury (Elliott-Hunt et al., 2004) . To test if galn mutants exhibit increased neuronal apoptosis after seizures, we stained galn int3/int3 mutants and galn +/+ larval brains for activated Caspase-3 after exposure to 10 mM PTZ. Neither galn +/+ nor galn int3/int3 larval brains showed increases in activated Caspase-3 signal at the PTZ dose applied (Fig. S5A ). Galn has also been ascribed antiepileptic properties (Podlasz et al., 2018) . To assess seizure susceptibility in galn int3/int3 , we treated larvae with an intermediate low dose of PTZ and counted high amplitude swim bouts as a measure of behavioural seizures (Baraban et al., 2005) . galn int3/int3 mutants did not exhibit spontaneous behavioural seizures at baseline and responded similarly as galn +/+ larvae to PTZ (Fig. S5B ), indicating that, unlike other seizure-susceptible zebrafish mutants (e.g. cntnap2; (Hoffman et al., 2016) ), galn mutants are not more sensitive to the convulsant effect of PTZ.
Galn is required for homeostatic rebound sleep after both pharmacologically-induced neuronal activity and sleep deprivation
To test whether galn is necessary for pharmacologically-induced rebound sleep, galn int3/int3 , galn int3/+ and galn +/+ siblings were exposed to 1 hour of vehicle, PTZ or caffeine and behaviourally tracked for rebound sleep after washout. As expected, Although pharmacologically-induced neuronal activity triggers rebound sleep in larval zebrafish that satisfies the behavioural criteria of sleep, the levels of neuronal activity induced by our assay are much higher than what animals naturally encounter acutely. To test whether Galn-dependent rebound sleep following high neuronal activity is a general mechanism relevant to sleep homeostasis, we sleep deprived galn mutants by physically extending wakefulness throughout the night.
We developed an opto-motor response (OMR) "treadmill" sleep deprivation (SD) assay, in which larvae are sleep deprived by presenting moving black/white stripes, a strongly salient swimming stimulus ( Fig. 5A , see Extended Methods). The control group was exposed to a stationary version of the same grating to account for environmental effects, such as changes in luminance. OMR SD over a 10 hour deprivation period spanning the circadian night, when larval sleep is most prevalent, increased sleep compared to undeprived controls the following day ( Fig.   5C ,D). This effect is due to the loss of sleep and not physical exhaustion, because comparable OMR exposure during the circadian day has no effect on sleep ( Fig.   5B ). Moreover, as in response to pharmacologically-induced neuronal activity, OMR SD at night induced subsequent galn expression ( Fig. 5E ). Importantly, galn is required for the increased rebound sleep following extended wakefulness by OMR SD, as galn +/+ but not galn int3/int3 mutants showed significant rebound sleep after one night of sleep deprivation (Fig. 5F ). Taken together, these results show that rebound sleep following both drug-induced neuronal activity and sleep deprivation engages galn, which is required for homeostatic rebound sleep in both paradigms.
Discussion

Decoupling sleep pressure from prior waking directly implicates global neuronal activity as a driver of sleep homeostasis
Measures of sleep pressure, including the magnitude of cortical slow wave activity (SWA) as well as the duration of rebound sleep, increase as a function of prior waking time (Borbely and Achermann, 1999; Borbely et al., 1981; Dijk et al., 1987; Dijk et al., 1990) . Most studies challenge the sleep homeostat through protocols that enforce extended wake. Our pharmacological sleep homeostasis assay, which converges onto the same regulatory mechanisms as physical sleep deprivation, allowed us to decouple sleep pressure from prior waking duration. Instead of waking time, physical vigor, or movement duration, we found that global neuronal activity, as measured by either c-fos expression or whole brain Ca 2+ imaging, was a potent predictor of subsequent homeostatic rebound sleep. We therefore propose that sleep pressure can be viewed not as a function of prior waking time but instead as a function of prior waking intensity, determined by the recruitment of neurons during wake.
Although rarely tested directly, our concept that the quality of waking activity contributes to sleep pressure is consistent with some previous experimental data in other species. In rats, exposure to a 1 hour social stress increased subsequent SWA to a similar degree as a 12 hour sleep deprivation (Meerlo et al., 1997) . Sleep deprivation techniques in mice that induce higher levels of c-fos expression, such as continual cage changes versus gentle handling, also build more sleep pressure as reflected in SWA during sleep rebound (Suzuki et al., 2013) . In humans, exposure to stimulating environments decreased sleep latency and increased sleep depth relative to stereotypical conditions (Horne and Minard, 1985) . More extremely, EEG recordings from patients suffering from chronic seizures revealed higher levels of SWA compared to healthy controls (Kaltenhauser et al., 2007; Schonherr et al., 2017) , and post-ictal fatigue is a common symptom in epilepsy patients (Ettinger et al., 1999; Hamelin et al., 2010) . Decoupling physical activity and total waking time from the sleep homeostasis machinery may also provide a mechanistic basis by which animals avoid rebound sleep pressure under extreme environmental or behavioral fitness pressures. For example, starved or courting flies significantly increase foraging or mating behavior with little apparent rebound sleep (Beckwith et al., 2017; Keene et al., 2010) , sandpiper males during mating season exhibit insomnia lasting days with little build-up of sleep pressure (Lesku et al., 2012) , and killer whale newborns and their mothers show almost no sleep during the first weeks after birth (Lyamin et al., 2005) . Perhaps under exceptional conditions, a kind of "behavioral autopilot" is engaged to minimize the recruitment of neurons to high firing rates and thus prevent the accumulation of sleep pressure.
For example, mice engaged in a stereotypical running wheel behavior show reduced firing rates in motor-and somatosensory cortical neurons and are capable of longer wake times (Fisher et al., 2016) . Similarly, in Drosophila, the thermogenic activation of distinct wake-promoting neurons that drive equal amounts of sleep loss induce various levels of subsequent rebound sleep (Seidner et al., 2015) , possibly because the number of neurons recruited during wakefulness varies.
Galanin as an output arm controlling homeostatic rebound sleep
The identity of the neuronal substrates on which homeostatic sleep pressure ultimately acts to drive rebound sleep are poorly understood. Our transcriptional, neuronal activation, and genetic lesioning data in the zebrafish converges on preoptic and hypothalamic Galn-expressing neurons as sensitive to increases in sleep pressure and required for rebound sleep after both pharmacological and physical sleep deprivation. In mammals, the Galanin expressing neurons of the ventrolateral preoptic area (VLPO) have been proposed to be a major sleep regulator. In rodents, up to 80% of sleep active neurons in the VLPO are Galanin expressing (Gaus et al., 2002) , lesioning the VLPO leads to insomnia in the rat (Lu et al., 2000) , and chemo-and optogenetic stimulation of VLPO Galanin expressing neurons increases sleep (Kroeger et al., 2018) . In aging humans, the loss of GALN neurons correlates with the reduction of sustained sleep (Lim et al., 2014) . Our results extend the importance of Galn for sleep/wake regulation, demonstrate that this role is evolutionarily conserved in vertebrates, and place Galn neurons as a critical output arm of sleep homeostasis.
Our data suggest a model in which Galn neurons are capable of sensing the global state of brain activity (either directly or indirectly), converting this signal into transcriptional and neuronal changes, and driving behavioral rebound sleep. We found that galn transcription is not only a functional readout of prior neuronal activity levels but that the level of galn induction strongly reflects rebound sleep time. How Galn expressing neurons are capable of integrating widespread neuronal activity to modulate their functional properties is unclear, but possibilities range from the direct detection of sleep-regulatory substances produced during wakefulness to indirect modulation of upstream neurons that then act on downstream galn circuits to alter their excitability. For example, Galn neurons of the mammalian VLPO are directly activated by adenosine (Gallopin et al., 2005) , while in zebrafish, galn transcription is upregulated by sleep-inducing Prokineticin 2 circuits .
We also show that genetic lesions of galn greatly reduce total rebound sleep in two separate assays, demonstrating that galn is required for converting sleep pressure into changes in homeostatic sleep behavior. In flies, the sleep promoting neurons that project to the dorsal fan-shaped body of the central complex, which has been likened to the mammalian VLPO, use the Galn orthologue Allatostatin for inhibition of arousal and have been suggested to act as a gate to regulate homeostatic sleep need (Donlea et al., 2018) . A similar mechanism could apply in our model, where sleep pressure increases as a result of neuronal activity to dose-dependently regulate the activity or excitability of galn neurons. Consistent with this idea, in rodents, the sleep-active and predominantly Galanin expressing neurons of the VLPO have been shown to increase their firing rate in response to sleep deprivation and during rebound sleep, with firing returning to baseline levels as EEG delta power decreases (Alam et al., 2014) . Identifying the downstream circuits that are directly modulated by galn neurons to drive rebound sleep will be an important next step to obtain a full picture of how these neurons participate in orchestrating sleep behavior.
Our study significantly expands the current understanding of homeostatic sleep regulation by demonstrating that galn is required to generate appropriate rebound sleep. However, it is unlikely that Galn is the sole regulator of homeostatic sleep, as galn mutants retain some homeostatic responses after very strong arousing stimuli (e.g. after 2mM caffeine exposure, Fig. S4I ). In addition, the modest reduction of normal sleep at night in galn mutants under baseline condition points to other, as yet undiscovered, regulators of zebrafish sleep. While much remains unknown about the molecular signals upstream of Galn neuron activity, how these signals integrate spatially extensive neuronal activity on long timescales of wakefulness, and what circuits lie downstream of Galn neurons to affect rebound sleep, the simplicity and scalability of our pharmacologically-induced rebound sleep assay paves the way for future screens aimed at uncovering these processes. (C,C') Dorsal and lateral MAP-maps obtained from 6 dpf larvae exposed to 2 mM caffeine (n=22) or control (n=24) for 1h and allowed to recover for 4h after washout. 
Supplementary Table 1
Table shows a list of anatomical regions and cell type labels containing functional signals from the MAP-maps ( Fig. 5 and S5 , see Extended Methods) and the registered galn ISH after comparing the signal distribution with the Z-Brain atlas.
Supplementary Movie 1-3
Videos show whole brain Ca 2+ imaging of representative Tg(elav3:H2B-GCaMP6s) larval brains recorded over 5 min at 5.5 fps and replayed at 500 fps. Movie 1 -5 µM aconitine; Movie 2 -1 mM caffeine; Movie 3 -10 mM PTZ.
Materials and Methods
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Zebrafish husbandry and experiments were conducted following standard UCL fish facility protocols under project licenses 70/7612 and PA8D4D0E5 awarded to JR from the UK Home Office, according to the UK Animals (Scientific Procedures) Act 1986. Zebrafish AB/TL larvae were studied before the onset of sexual maturation between 5-7 dpf. The age of the animals used is described in the STAR Methods and/or indicated in the figures.
Mutant zebrafish galn int3/int3 and galn i8/i8 mutant
galn mutants were generated on a AB/TL background using CRISPR/Cas9 mutagenesis (Hwang et al., 2013) by co-injection of Cas9 mRNA with the sgRNA target sequence 5'-CGGACTCACGAGGACCGAGGA-3', which is identical in sequence to the boundary of galn exon3/intron3. Putative F0 founders harbouring somatic mutations were identified by PCR amplification (primers as below) of a 117 base pair sequence with adaptor arms from tail genomic DNA using a benchtop Illumina sequencing machine (MiSeq). The mutant galn int3 allele harbors a 43 bp deletion spanning the exon3/intron3 boundary causing the loss of the splice donor site in intron3. The galn int3 and wild type alleles were genotyped using the primers 5'-ATGTACTGTCCTCATGGCAAAG-3' and 5'-AAATGTAGACCTGAGAGCAGC-3', WT (512 bp) and mutant PCR products (469 bp) were separated by gel electrophoresis on a 2% agarose gel. The mutant i8 allele contains an 8 bp insertion leading to a frame shift and premature stop codon in both galn isoforms. The galn i8 and wild type alleles were genotyped as above and wild type and mutant PCR products were separated by gel electrophoresis on a 3% agarose gel. Both galn mutant alleles are homozygous fertile and lack any overt morphological or behavioral phenotypes apart from a disorganisation/lack of pigmented stripes which is most likely due to an impairment of xanthophore/irodophore development, as melanophores appear unaffected.
METHOD DETAILS
Locomotor activity assay
Behavioral tracking of larval zebrafish was performed as previously described (Prober et al., 2006; . Zebrafish larvae were raised on a 14:10 light:dark cycle at 28.5°C and at 5 dpf placed into individual wells of a square-well 96-well plate (Whatman) containing 650 µl of standard embryo water (0.3 g/L Instant Ocean, 1 mg/L methylene blue, pH 7.0). Water levels were topped up each morning at the beginning of the light period (9 a.m.) (visible as an additional morning peak in the galn mutant behavior traces). Locomotor activity was monitored using an automated videotracking system (Zebrabox, Viewpoint LifeSciences) in a temperature-regulated room (26.5 o C) and exposed to a 14:10 white light:dark schedule with constant infrared illumination (Viewpoint Life Sciences). Larval movement was recorded using the Videotrack quantization mode with the following detection parameters: detection threshold, 20; burst, 100; freeze, 3; bin size, 60s, which were determined empirically. At 6 dpf drugs or vehicle alone were added to the individual wells between 10 and 11 a.m. for one hour. Tracking was then paused and larvae were individually placed into 20 cm dish containing embryo water for 5s before being transferred into the well of a fresh 96-well plate corresponding to the larva's previously tracked well. Tracking was continued until at least the following day. Behavioral tracking of galn mutants was performed blinded from heterozygous galn/+ x galn/+ incrosses. Larvae were genotyped as described above after completion of the experiment and genotypes assigned to wells for data analysis. The locomotor assay data were analyzed using custom MATLAB (MathWorks) scripts. Any one-minute period of inactivity was defined as one minute of sleep (Prober et al., 2006) . Sleep bout length describes the duration of consecutive, uninterrupted minutes of sleep whereas sleep bout number counts the occurrence of such events during a given time period. Average activity represents the total ΔPixel change over time whereas waking activity excludes rest bouts.
Inactivity reversibility assay
To test the reversibility of inactivity after drug exposure, larvae were exposed to 10min dark pulses to induce a startle with the first lights-OFF period 20min after drug washout, then every 2.5h until the circadian lights-OFF period (11 p.m.). The response was measured as Δactivity, which was determined for each individual larva by subtracting the mean activity 10min prior to the dark pulse from the mean activity during the 10min dark light period. For pulses 2-4, which on a population level were statistically not significantly different to each other, the average Δactivity response of each larva was calculated.
Arousal threshold assay
The arousal threshold assay was performed as previously described . After 1h exposure to 5mM PTZ at 6 dpf, the drugs were washed-out as described above and taps of 14 different intensities were randomly applied over an 8h period (1 p.m. to 9 p.m.). Thirty trials were performed at each stimulus strength, with a 1min interval between trials. The probability of movement independent of the stimulus was calculated by identifying the fraction of larvae for each condition that moved 5s prior to all stimuli delivered. This value was subtracted from the average response fraction value for each tap event. Any movement occurring within 1s of a tap was counted as a response. The curves were analysed using the createFit_v1(x, y) MATLAB function (MathWorks).
Sleep deprivation (OMR)
For sleep deprivation using the optomotor response (OMR), 100 larvae were transferred into two clear, square 12 cm petri dishes (Greiner, 688102) in standard embryo water and at 8 p.m. placed above a monitor displaying either a moving (25mm/s) or non-moving grating pattern (control), consisting of black and white vertical stripes. To keep larvae at a constant ambient temperature a fan provided constant air circulation and the water temperature as well as illumination levels were monitored over the course of the experiment. At 10.30 a.m. the following day, 48 larvae of each condition were placed into individual wells of a 96-well plate and their locomotor activity tracked for the next 24h (see above). Exposure of larvae to OMR during the day started at 10.30 a.m. for the duration of 10h. Larvae were then individually tracked for 14h in constant light condictions to assess sleep/wake behaviour.
Drug exposure for ISH/IHC/qRT-PCR
Wild type larval zebrafish from the same clutch were raised on a 14:10 light:dark cycle at 28.5°C with lights on at 9 a.m. and off at 11 p.m. At 6 dpf, larvae were transferred to a 6-well plate at a density of up to ~5 fish/mL. At 10:30 a.m. vehicle or drugs were added (concentrations for each experiment are indicated in the figure or figure legend). Larvae were placed in the 28.5°C incubator for 1 hour, after which drugs were washed out and larvae transferred to a new 6-well plate with fresh water. For samples treated for pERK/tERK stainings, larvae were placed into a sieve, which was fitted in each well to facilitate a rapid and consistent fixation across treatment groups and to minimise artifacts in the pERK signal . After a 4-hour recovery period in the incubator, larvae were quickly fixed by immersing the sieve into a new 6-well plate containing 4% paraformaldehyde (PFA) in phosphate buffered saline (pH 7.3, PBS) + 4% sucrose and left overnight at 4°C.
Whole-mount in situ hybridisation (ISH)
Larvae were fixed in PFA with 4% sucrose overnight at 4°C, transferred into PBS the next morning and the brain dissected by removing skin, cartilage and eyes with forceps. ISH was performed following standard protocols using digoxigenin (DIG)-11-UTP-labelled antisense riboprobes targeting the gene transcript of interest (Thisse and Thisse, 2008) . Probe hybridization was carried out in hybridization buffer supplemented with 5% dextran sulphate overnight at 65°C. The larvae were then incubated overnight at 4°C with anti-Dig-AP (1:2000 in 5% normal goat serum) and extensively washed before detecting alkaline phosphatase using NBP/BCIP. The antisense c-fos riboprobe was transcribed from plasmid after subcloning a 716 bp PCR product generated using primers 5'-CCGATACACTGCAAGCTGAA-3' and 5'-ATTGCAGGGCTATGGAAGTG-3' (digestion with BamHI, transcribed with T7 RNA polymerase). The galn riboprobe has been previously described . Fluorescent ISH was essentially performed as above but probe detection was carried out with an anti-Dig-HRP antibody (1:1000 in 5% NGS). Samples were then developed with the Cy3 TSA® Plus Fluorescence System (Perkin-Elmer, NEL753001KT), larval brains were mounted in 80% glycerol / 1% low melting agarose and imaged using a Leica SP8 confocal microscope with a 25x objective (0.95 NA, water immersion). DAPI was used as a nuclear counterstain. Imaris Image Analysis Software (Bitplanes) was used to count the sum voxel intensity in the selected regions of interest (ROI), which were defined the same size across samples. Mean and median was calculated for larvae processed in the same experiment.
Immunohistochemistry (IHC)
Larvae were fixed in 4% PFA with 4% sucrose for 2h (Galanin IHC) or 6h (all other) at room temperature (RT) prior to brain dissection (see above). The samples were washed and pre-incubated with blocking solution in PBS containing 0.25% Triton X-100 (PBS-Tr) with 2% dimethyl sulfoxide (DMSO) supplemented with 2% NGS and for 2h prior to incubation with the primary antibody over night at 4°C. After thorough washing in PBS-Tr, the larvae were incubated with the secondary Alexa antibody (1:500) and DAPI (1 mg/ml stock, 1:1000) overnight at 4°C. Samples were imaged as specified above.
Immunohistochemistry (IHC) for pERK/tERK staining
Brains were manually dissected and immunostained as previously described ). Briefly, samples were washed in PBS-Tr three times for 5 min on a shaker, and incubated in 0.05% Trypsin-EDTA for 45 min on ice. After three 5 min washes in PBS-Tr, samples were blocked in PBT + 2% NGS + 1% bovine serum albumin (BSA) + 1% DMSO at RT on a shaker for at least 1 hour. Primary antibody incubations were performed overnight at 4°C on a shaker in PBS-Tr + 1% BSA + 1% DMSO using mouse anti-tERK (1:500) and rabbit anti-pERK (1:500). Samples were washed three times for 15 min in PBS-Tr at RT and secondary antibody incubations were performed overnight at 4°C on a shaker in PBS-Tr + 1% BSA + 1% DMSO using Alexa Fluor 488 goat anti-rabbit (1:200) and Alexa Fluor 568 goat anti-mouse (1:200). Finally, samples were washed three times for 15 min in PBS-Tr at RT and then left in PBS-Tr rotating at 4°C until mounting. To allow registration of the signal obtained by fluorescent ISH against galn, brains were immunostained as described above using mouse anti-tERK (1:500) as primary antibody and Alexa Fluor 568 goat anti-mouse (1:200) as secondary antibody.
Image acquisition, Z-brain registration and MAP-mapping
Stained samples were imaged in a custom-built 2-photon microscope (Bruker), using a 20x water-immersion objective (1.0 NA, OLYMPUS) and Prairie View acquisition software. Brains were mounted dorsal-side up in 1.5% low melting point agarose and full-brain stacks were acquired at a voxel size of 0.584/0.584/2 µm (x/y/z) with a laser wavelength of 800 nm and a laser intensity of 40-80 mW. Brains that underwent fluorescent ISH against galn together with IHC against tERK were imaged using a Leica SP8 confocal microscope with a 25x objective (Olympus, 0.95 NA, water immersion at a voxel size of 0.606/0.606/1.5 µm (x/y/z). Analysis was performed using MATLAB (MathWorks) and Fiji. Non-rigid image registration was performed using the Computational Morphometry Toolkit (CMTK, http://www.nitrc.org/projects/cmtk/) as previously described . tERK staining was used to register the samples to the Z-brain atlas reference brain and then used to align pERK stainings, as well as the galanin FISH labeling. Calculation of MAP-maps was done using the "MakeTheMAPMap.m" Matlab function as previously described . Maximum-intensity projections of MAP-maps were obtained after resizing the raw MAP-maps to 621x1406 pixels and 138 slices in Fiji. Lateral views of maximum-intensity projections of MAP-maps were obtained by resizing the stacks to 276 slices depth and reslicing them in Fiji (1 micron output spacing, start at left, rotate 90 degrees, avoid interpolation). To further analyse and quantify the MAP-map signals as well as the signal from the registered galn ISH, we compared their distribution with the regions and cell type labels in the Z-Brain atlas using the "ZBrainAnalysisOfMAPMaps.m" MATLAB function as previously described ( Supplementary Table 1 ).
Quantitative real-time PCR (qRT-PCR)
For qRT-PCR analysis, 30-40 whole larvae in minimal medium were snap frozen in liquid nitrogen. RNA was isolated using TRIzol™ Reagent (Invitrogen, 15596026) and treated with DNaseI (NEB, M0303). 1 µg of RNA was reverse transcribed with AffinityScript (Agilent, 600559) the resulting cDNA was diluted 1:20. Expression levels were measured using GoTaq® qPCR Master Mix (Promega, A6002) in technical triplicates on a BioRad iCycler. For each primer set, efficiency and specificity was first determined using standard curves of diluted cDNAs and melting curve analysis. Expression of galn and fosab (c-fos) was normalized to expression of ef1a1l1 and relative expression levels were calculated using the ΔΔCt method. Statistical tests for differences are indicated in the figure legends. Primers for amplification: galn, 5'-AAGGATACTCCCAGTGCAAGG-3' and 5'-CTTTCCTGCCAGTCCGTGTT-3'; fosab, 5'-GTGCAGCACGGCTTCACCGA-3' and 5'-TTGAGCTGCGCCGTTGGAGG-3' ; ef1a1l1, 5'-TGCTGTGCGTGACATGAGGCAG-3' and 5'-CCGCAACCTTTGGAACGGTGT-3'.
Wide field Calcium (Ca 2+ ) imaging
Wide field microscopy imaging of whole brain Ca 2+ signals was performed as previously described with the following modifications . Neuronal activity was measured in 6 dpf larvae expressing the genetically-encoded calcium indicator GCaMP6s under the pan-neuronal promoter elav3 (Tg(elavl3:GCaMP6s)). Larvae were mounted in a drop of 3% low melting agarose in standard embryo medium in a 35 mm petri dish (Falcon, 353001) and the dish filled with standard embryo medium. Imaging was performed on an upright MVX10 MacroView microscope using an MC PLAPO 1x objective (both OLYMPUS) with a mercury lamp for fluorescent excitation (OLYMPUS, U-HGLGPS). The fluorescence signal was recorded with XM10 OLYMPUS camera at 5.5 frames per second (fps). Baseline was recorded twice over a 5 min period prior to addition of the drug or vehicle control. After exposure to DMSO, 10 mM PTZ or 5 µM aconitine, fluorescence was immediately recorded for 5 min every 5 min over a 65 min period (total of 7x5 min recordings). The GCaMP6s fluorescence signal was measured using ImageJ by manually selecting the brain as the region of interest (ROI). After background subtraction, ΔF/F was calculated using the mean pre-drug baseline fluorescence. For global comparison between conditions, the fluorescence per min (normalised to pre-treatment baseline) was calculated for each of the 5 min recordings and the average taken over the 7 repeats.
QUANTIFICATION AND STATISTICAL ANALYSIS
For behavioral experiments, after testing for deviations from normality, Kruskal-Wallis multiple comparison followed by Dunn-Sidak post-hoc test was used to assess statistical significance. For galn and c-fos qPCR to measure induction of expression, one-way ANOVA with post hoc Dunnett's test for comparisons to controls was used. Quantification of galn expression time course post PTZ and return to baseline the following day was tested for significance using one-way ANOVA for pairwise comparisons of the mean of each sample to its timed control with post hoc Bonferroni correction for multiple comparisons. Differences in galn expression using fluorescent ISH were assessed by Kruskal-Wallis multiple comparison followed by Dunn-Sidak post-hoc test. Statistical analysis of galn mutants in response to OMR SD was assed by twoway Anova (genotype x drug condition) followed by a Tukey-Kramer post-hoc test. Figure S5 
